| 13th Sep 2021 5:26 pm |
RNS |
Director/PDMR Shareholding |
| 9th Sep 2021 4:42 pm |
RNS |
Director/PDMR Shareholding |
| 7th Sep 2021 4:54 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Sep 2021 9:32 am |
RNS |
Director/PDMR Shareholding |
| 1st Sep 2021 11:44 am |
RNS |
Total Voting Rights |
| 31st Aug 2021 7:00 am |
RNS |
SK bio & GSK start Ph3 Covid-19 vaccine trial |
| 25th Aug 2021 2:01 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Aug 2021 4:39 pm |
RNS |
Director/PDMR Shareholding |
| 13th Aug 2021 9:38 am |
RNS |
Director/PDMR Shareholding - amendment |
| 11th Aug 2021 2:18 pm |
RNS |
Director/PDMR Shareholding |
| 11th Aug 2021 12:34 pm |
RNS |
Director/PDMR Shareholding |
| 5th Aug 2021 9:00 am |
RNS |
Block Listing Application |
| 2nd Aug 2021 2:23 pm |
RNS |
Total Voting Rights |
| 28th Jul 2021 5:32 pm |
RNS |
Director/PDMR Shareholding |
| 28th Jul 2021 12:00 pm |
RNS |
2nd Quarter Results |
| 26th Jul 2021 4:59 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Jul 2021 2:32 pm |
RNS |
Board Committee Changes |
| 22nd Jul 2021 2:45 pm |
RNS |
CEO Designate of new Consumer Healthcare company |
| 16th Jul 2021 12:00 pm |
RNS |
GSK announces daprodustat phase 3 headline results |
| 16th Jul 2021 10:24 am |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2021 1:21 pm |
RNS |
Director/PDMR Shareholding |
| 14th Jul 2021 3:34 pm |
RNS |
Director/PDMR Shareholding |
| 14th Jul 2021 3:17 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jul 2021 9:44 am |
RNS |
Director/PDMR Shareholding |
| 13th Jul 2021 9:33 am |
RNS |
Director/PDMR Shareholding |
| 12th Jul 2021 10:23 am |
RNS |
Director/PDMR Shareholding |
| 12th Jul 2021 10:18 am |
RNS |
Director/PDMR Shareholding |
| 9th Jul 2021 9:30 am |
RNS |
Director/PDMR Shareholding |
| 2nd Jul 2021 12:36 pm |
RNS |
GSK and Alector collaboration in immuno-neurology |
| 2nd Jul 2021 10:41 am |
RNS |
Elliott Advisors (UK) letter to GSK |
| 1st Jul 2021 2:29 pm |
RNS |
Total Voting Rights |
| 25th Jun 2021 4:54 pm |
RNS |
Director/PDMR Shareholding |
| 24th Jun 2021 11:07 am |
RNS |
Director/PDMR Shareholding |
| 23rd Jun 2021 11:00 am |
RNS |
GSK to deliver step-change in growth & performance |
| 22nd Jun 2021 7:00 am |
RNS |
ViiV/Halozyme sign exclusive licensing agreement |
| 14th Jun 2021 11:58 am |
RNS |
GSK and iTeos announce collaboration for EOS-448 |
| 11th Jun 2021 4:54 pm |
RNS |
Director/PDMR Shareholding |
| 9th Jun 2021 3:28 pm |
RNS |
Director/PDMR Shareholding |
| 4th Jun 2021 4:02 pm |
RNS |
GSK recommend ADR holders reject mini-tender offer |
| 1st Jun 2021 11:33 am |
RNS |
Total Voting Rights |
